Patton Fund Management, Inc. Abb Vie Inc. Transaction History

Patton Fund Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	SELL	$144.61 - $166.54 $728,111 - $838,528	-5,035 Reduced 35.04%	9,335 $1.49 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $6,915 - $8,293	50 Added 0.35%	14,370 $2.32 Million
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $170,446 - $195,491	-1,270 Reduced 8.15%	14,320 $1.92 Million
Q2 2022 Jul 22, 2022	BUY	$137.62 - $174.96 $2.15 Million - $2.73 Million	15,590 New	15,590 $2.39 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Patton Fund Management, Inc. with notifications on news.